Memory Pharmaceuticals News
Most Popular Memory Pharmaceuticals Story
Roche snaps up Memory Pharma for $50M
Roche is buying Memory Pharmaceuticals for $50 million. The pharma giant is paying 61 cents a share, a big premium over Memory's bottom-dwelling price of 15 cents a share. For Roche, it's a chance to Read more...
Latest Headlines
- October 1, 2009
- November 25, 2008
- September 18, 2008
- May 2, 2008
- March 12, 2008
- November 2, 2007
- October 15, 2007
- March 4, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
